Skylight Health Group Inc. (SLHGF)
OTCMKTS: SLHGF · Delayed Price · USD
0.0000
-0.0001 (-99.00%)
Feb 28, 2024, 4:12 PM EDT - Market closed
Skylight Health Group Market Cap
Skylight Health Group has a market cap or net worth of $6.00 thousand as of March 28, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
6.00K
Enterprise Value
n/a
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since June 7, 2021, Skylight Health Group's market cap has decreased from $206.20M to $6.00K, a decrease of -100.00%. That is a compound annual growth rate of -99.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 24, 2022 | 23.30M | -1.69% |
Aug 23, 2022 | 23.70M | -0.84% |
Aug 22, 2022 | 23.90M | 2.14% |
Aug 19, 2022 | 23.40M | -5.26% |
Aug 18, 2022 | 24.70M | -0.40% |
Aug 17, 2022 | 24.80M | -5.70% |
Aug 16, 2022 | 26.30M | -6.74% |
Aug 15, 2022 | 28.20M | 1.44% |
Aug 12, 2022 | 27.80M | -1.42% |
Aug 11, 2022 | 28.20M | 5.22% |
Aug 10, 2022 | 26.80M | -5.63% |
Aug 9, 2022 | 28.40M | 3.65% |
Aug 8, 2022 | 27.40M | -5.84% |
Aug 5, 2022 | 29.10M | 3.56% |
Aug 4, 2022 | 28.10M | 2.55% |
Aug 3, 2022 | 27.40M | -12.18% |
Aug 2, 2022 | 31.20M | 10.64% |
Aug 1, 2022 | 28.20M | 6.42% |
Jul 29, 2022 | 26.50M | -0.38% |
Jul 28, 2022 | 26.60M | 5.56% |
Jul 27, 2022 | 25.20M | 4.56% |
Jul 26, 2022 | 24.10M | 2.12% |
Jul 25, 2022 | 23.60M | -0.42% |
Jul 22, 2022 | 23.70M | -6.69% |
Jul 21, 2022 | 25.40M | 26.37% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 736.75B |
Novo Nordisk | 572.70B |
UnitedHealth Group | 455.99B |
Johnson & Johnson | 375.37B |
Merck & Co. | 317.90B |
AbbVie | 317.69B |
Thermo Fisher | 216.90B |
AstraZeneca | 210.91B |